A comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspective Therapeutic monoclonal antibodies have become an increasingly successful treatment modality with sales of US$ 65 bln in the year 2012 and with an average (continuous) annual growth rate from 2006 to 2012 of 18.9%. While antibody technologies are steadily evolving, the spectrum of druggable targets for monoclonal antibodies has remained limited to extracellular antigens, albeit including proteins, carbohydrates and glycolipids.
A Technology & Pipeline Assessment and Corporate Benchmarking Analysis The report “Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares: Technology & Pipeline Assessment and Corporate Benchmarking Analysis” of June 2013 describes a market forecast based on growth of historical sales of recombinant coagulation factors. The report evaluates reasons for failures of novel recombinant coagulation factors and provides detailed profiles of active recombinant coagulation factors in clinical development.
The analytical report „Influence of Antibody Attributes on Clinical Success – A Technology and Coporate Benchmark Analysis“ evaluates the impact of a number of antibody attributes on the success rate of antibodies in clinical development. Among the antibody attributes studied in this investigation are antibody generation technology, animal species of the parental antibody, antibody format, immunoglobulin class and isotype, target, and therapeutic area. Information from more than 500 naked recombinant monoclonal antibodies was used for this research. Antibodies which failed in clinical development were further analyzed for the reason of failure and phase in which they were discontinued.
This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in 2014, the overall market for cancer therapeutics stood at about $84.3 billion.
Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not until November 1998 that a technique was developed to isolate and grow embryonic stem cells from human blastocysts.
Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types.
The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within most developing nations.
Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body.
The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within several developing nations.
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells.
Overview: Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system.
The Polyacetal (POM) volume market is expected to reach 2.2 million tons by 2018 primarily supported by the application sector. Globally, Automotive and Industrial together account for approximately 51.34% of the market share are expected to support the Polyacetal (POM) industry going forward. Geographical analysis for Polyacetal (POM) shows that the highest Compounded Annual Growth Rate (CAGR) of 6.9% is anticipated from Asia-Pacific region followed by The Americas with a CAGR of 4.5% during the analysis period 2012-2018.
The Polyamides volume market is expected to reach 8.7 million tons by 2018 primarily supported by the product type and application sector. Globally, Transportation and Textiles and Sporting together account for approximately 44.9% (2015) of the market share are expected to support the Polyamides industry going forward. Geographical analysis for Polyamides shows that the highest Compounded Annual Growth Rate (CAGR) of 6.9% is anticipated from Asia-Pacific region followed by The Americas with a CAGR of 6.1% during the analysis period 2012-2018.
The Polyamide 6 volume market is expected to reach 4.6 million tons by 2018 primarily supported by the application sector. Globally, Transportation and Textiles and Sporting together account for approximately 44.51% (2015) of the market share are expected to support the Polyamide 6 industry going forward. Geographical analysis for Polyamide 6 shows that the highest Compounded Annual Growth Rate (CAGR) of 6.4% is anticipated from Asia-Pacific region followed by The Americas with a CAGR of 5.5% during the analysis period 2012-2018.
The Polyamide 66 volume market is expected to reach 3.5 million tons by 2018 primarily supported by the application sector. Globally, Transport and Household /Industrial Engineering together account for approximately 48.96% (2015) of the market share are expected to support the Polyamide 66 industry going forward. Geographical analysis for Polyamide 66 shows that the highest Compounded Annual Growth Rate (CAGR) of 7.5% is anticipated from Asia-Pacific followed by The Americas with a CAGR of 6.6% during the analysis period 2012-2018.
The Specialty Polyamides volume market is expected to reach 5801.9 hundred tons by 2018 primarily supported by the application sector. Globally, Transport and Packaging together account for approximately 38.44% (2015) of the market share are expected to support the Specialty Polyamides industry going forward. Geographical analysis for Specialty Polyamides shows that the highest Compounded Annual Growth Rate (CAGR) of 8.7% is anticipated from Asia-Pacific region followed by The Americas with a CAGR of 7.8% during the analysis period 2012-2018.
Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 40% by 2015 leaving the rest of the market to the bare metal stents and other devices. By Coating, Polymer stent coating segment is the fastest growing market with a CAGR of 8.7% for analysis period 2012-2018.
BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug Eluting Stents account more nearly half of the market value while Absorbable Stents segments indicate a close 14%. In case of Stent Coating, Polymer depicts the largest CAGR while Non-Polymer and Inorganic in second and third place respectively.
Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally. Microarrays segment accounts for nearly 70% of the industry value while services indicate lesser than 15% of the market value.
BRICSS Electrophysiology (EP) Laboratory Devices market value is expected to reach US$123 million by 2016, primarily supported by the product types - X-Ray Systems, Remote Steering Systems, Radiofequency (RF) Ablation Generators and …etc. China accounts for nearly 26% of the market share and India claims more than 23%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, X-Ray Systems market value indicates a close to 35% by 2015 leaving the rest of the market to other types.
BRICSS Electrophysiology (EP) Ablation Catheters market value is expected to reach US$66 million by 2016, primarily supported by the product types - Radiofequency (RF) EP Ablation Catheters, Navigational Advanced Mapping Accessories and …etc. China accounts for nearly 24% of the market share and India claims more than 26%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Radiofequency (RF) EP Ablation Catheters market value indicates more than 35% by 2015 leaving the rest of the market to the other types.
Following on from our “Nanotechnology for Drug Delivery” series of reports we are turning the focus onto medical diagnostics with our latest report: “Nanotechnology for Medical Diagnostics” Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease,
This market insight report on Amino Acids analyzes the market by Type and Application at global level and for each of the geographic regions - North America, Europe, China, Asia-Pacific, Latin America and Rest of World. The Amino Acids market is segmented by Type into Glutamate, Lysine, Methionine, Branched Chain Amino Acids and Phenylalanine; and by Application into Feed Additives, Food Ingredients, and Nutraceuticals/Pharmaceutical. Business profiles of 11 major companies and 79 competitor companies are discussed in the report.
This report gives a market insight into the ever progressing and debatable market of Stem Cells, segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells and Other. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other.
The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- North America, Europe, Asia-Pacific and Rest of World.
This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management.
This report covers both products and services in the RNAi industry. The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- North America, Europe, Asia-Pacific and Rest of World. The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, miRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and Electroporation), Monitoring/Optimizing (Primers for RTqPCR, Controls, and miRNA Detection Tools), and Libraries (Human, Mouse, and Rat).
This market insight report on Biotechnology in India covers products, technologies and services used in the Indian Biotechnology Industry. The report studies the Bio Pharma, Herbal Drugs, Bioservices and Bioindustrial markets in detail. Market estimations and predictions are illustrated by sector and by technology.
Advancements in antibody technology has revolutionized both the diagnostic and therapeutic sciences. As of today, monoclonal antibodies can be produced virtually against any antigen and they have transformed the diagnostic industry in view of their specificity towards specific antigens and almost unlimited production capabilities. In the field of therapeutics, they have changed the treatment possibilities and significantly improved the life expectancies of patients who were earlier having very high unmet needs.
With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, is expected to be more akin to a marathon than a sprint. IMARC Group, one of the world’s leading research and advisory firms, in its new report “Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)” finds that biosimilars in the US will soon represent a multi-billion dollar market as they would be posing stiff competition to as many as twenty biological molecules during 2011-2020.
This new market research report forecasts on Biotechnology Market providing complete market figures, consisting market size and estimation by Biotechnology Market application and products depending upon geographical location for the forecasting period 2012 to 2022.
This new market research report forecasts on Genomics Market providing complete market figures, consisting market size and estimation by Genomics Market application and products depending upon geographical location for the forecasting period 2012 to 2022.
This new market research report forecasts on Circulating Tumor Cells Market providing complete market figures, consisting market size and estimation by Circulating Tumor Cells Market application and products depending upon geographical location for the forecasting period 2012 to 2022.
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
China's demand for Biologics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Agricultural biotechnology is set of scientific methods and tools which can be utilized on plants or living creatures or on both of them concurrently to enhance the output of the crops. It is mainly utilized to change the sequence of genome of agricultural crops which are referred as genetically tailored or transgenic.
Biosimilars Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2017 - 2025, the Biosimilars market was valued at US$ 3.52 Bn in 2016, and is expected to reach US$ 25.83 Bn by 2025, expanding at a CAGR of 23.1% from 2017 to 2025.
GBI Research’s latest report, "Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook" discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic purpose. It includes not only the insertion of a gene into the cell for expression, but also gene silencing with RNA interference (RNAi) and antisense RNA, aptamers (DNA or RNA polymers which bind to a protein target), and oncolytic viruses.
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
Summary
The lupus therapeutics market is dominated by generics and GlaxoSmithKlines Benlysta is the only drug that has gained marketing approval for SLE in more than 50 years.
Oil and Chemicals Storage Industry Outlook in Middle East to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Summary
"Oil and Chemicals Storage Industry Outlook in Middle East to 2019 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals" is a comprehensive report providing information on storage terminals that store crude oil, petroleum products or, chemicals in Middle East.
Norway Aasta Hansteen Project Panorama - Oil and Gas Upstream Analysis Report
Summary
Norway Aasta Hansteen Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset.
Global Capacity and Capital Expenditure Outlook for Gas Processing - United States, Russia, and Iran Underpin Proposed US$100 Billion Investment in Global Gas Processing Boom
Summary
The global gas processing industry is poised for substantial 13% growth over the next five years.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
The Global Bisphenol F Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Bisphenol F industry.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Bisphenol F market analysis is provided for the international market including development history, c
..
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Elemental Analysis market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Lipase market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
WinterGreen Research announces that it has published a new study Refinery, Re-refinery, and Bio Fuel Catalysts: Market Shares, Strategy, and Forecasts, Worldwide, 2016 to 2022. The 2016 study has 36 pages, 18 tables and figures in excel. Worldwide Refinery, Re-refinery, and Bio Fuel Catalysts markets are poised to achieve significant growth with the shift in types of feedstock being processed.
Clustered regularly-interspaced short palindromic repeats also known as CRISPR is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology.
This report mainly covers the following Product types including
Totipotent stem cell
Pluripotent stem cell
Unipotent stem cell
Others
This report Mainly covers the following product types
Chondrocytes
Osteoblasts
Adipocytes
Myocytes
Beta-pancreatic islet cells
Neuronal cells
This report mainly covers the following
The segment applications including
Blood diseases
Autoimmune diseases
Others
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Trauma Cleaning Machine market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
This report studies Biocompatible Material in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report studies sales (consumption) of Labeling and Linkage Agents for Immunoassays in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering
Abbott Laboratories
Affymetrix
Beckman-Coulter
This report studies sales (consumption) of Labeling and Linkage Agents for Gene Probes in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering
Abbott Laboratories
Affymetrix
Beckman-Coulter
This report studies sales (consumption) of Immunoglobulin in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering
Baxter International
Biotest AG
China Biologics Products
CSL Behring
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Western Blot Imager market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
This report studies Western Blotting in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Thermo Fisher Scientific, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
GE Healthcare (U.K.)
Merck Millipore (U.S.)
This report studies sales (consumption) of Molecular Weight in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
F Hoffmann-La Roche AG (Switzerland)
Thermo Fisher Scientific Inc. (U.S.)
Agilent Technologies (U.S.)
Sigma-Aldrich (U.S.)
Affymetrix, Inc.(U.S.)
QIAGEN (Netherlands)
This report studies sales (consumption) of Live Cell Imaging in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Carl Zeiss AG (Germany)
Leica Microsystems (Germany)
Nikon Corporation (Japan)
Molecular Devices, LCC (U.S.)
PerkinElmer, Inc. (U.S.)
This report studies sales (consumption) of Cell Isolation Reagents in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
This report studies sales (consumption) of Cell Isolation Centrifuge in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
Miltenyi Biotec
Pluriselect Life Science
Stemcell Technologies Inc.
Terumo Bct (A Subsidiary of Terumo Corporation)
Bio-Rad Laboratories, Inc.
This report studies sales (consumption) of Cell Isolation Beads in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
This report studies sales (consumption) of Cell Culture Media in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
Miltenyi Biotec
This report studies Cell Isolation Reagents in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Beckman Coulter (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
Merck KGaA
Thermo Fisher Scientific Inc.
This report studies sales (consumption) of Imaging Agents in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bayer Healthcare Pharmaceuticals
Bracco Diagnostics
Daiichi Sankyo
Eisai
Eli Lilly and Company
EUSA Pharma
GE Healthcare
This report studies Transfection Technologies in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Life Technologies
Sigma Aldrich
Lonza
Promega
Qiagen
Bio-Rad
Roche
Polyplus Transfection
This report studies Mycoplasma Testing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
BioMerieux
2016 Global Medical Bionic Implant And Artificial Organs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Medical Bionic Implant And Artificial Organs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).
This report studies Dendrobium Luminous Pills in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
In this report, the global Smart Fingerprint Locks market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
In this report, the global Live Cell Imaging Equipments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report studies the global Animal Stem Cell Therapy market, analyzes and researches the Animal Stem Cell Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Global Liquid Biopsy Market was valued at $634 million in 2016, and is estimated to reach at $3,805 million by 2023, registering a CAGR of 28.9% from 2017 to 2023. Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories.
In this report, the United States Lysozyme market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
In this report, the United States Mice Model market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
In this report, the United States Recombinant Therapeutic Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
WinterGreen Research announces that it has published a new study Hearing Implants and Biomaterials: Market Shares, Strategy, and Forecasts, Worldwide, 2017 to 2023. The 2017 study has 162 pages, 88 tables and figures. Hearing Implants and Biomaterial markets are poised to achieve significant growth with increasing use of next generation metals, polymers, and ceramics set to enhance the value of hearing surgery and improve surgical outcomes.
This new market research report forecasts on Anaerobic Digesters Market providing complete market figures, consisting market size and estimation by Anaerobic Digesters Market application and products depending upon geographical location for the forecasting period 2017 to 2025.
In this report, the global Cranio Maxillofacial Fixation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
This report studies the global Microbial Identification Service market, analyzes and researches the Microbial Identification Service development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Acute Market Research recently added new report titled "Microalgae Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast - 2018 – 2026" to its repertoire. This latest industry research study scrutinizes the Microalgae market by different segments, companies, regions and countries over the forecast period 2018 to 2026.
Biotechnology algae cultivation process like algaculture is a form of aquaculture involving the farming of species of algae. The majority of algae that are intentionally cultivated fall into the category of microalgae (also referred to as phytoplankton, microphytes, or planktonic algae).
Agricultural biotechnology is set of scientific methods and tools which can be utilized on plants or living creatures or on both of them concurrently to enhance the output of the crops. It is mainly utilized to change the sequence of genome of agricultural crops which are referred as genetically tailored or transgenic. This has helped manufacturers, peasants and customers with huge crop output and best quality of food.
The global automated microbiology market is predicted to expand during the estimated period due to growing occurrence of pathogen induced ailments. In current years, detection of pathogens with the help of the automated microbiology has created large thrust, as it assists in early recognition of different infectious agents like fungus, parasite, virus, viroid, bacterium and prion. These agents are the cause of severe ailments like Chickenpox, Rubella, Mumps, Ebola, Smallpox and Influenza.
Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings. In the next few years the demand for rapid microbiology tests is expected to increase significantly in the emerging economies such as China and India.
This report on plant stem market for cosmetics studies various applications of plant stem cell-based cosmetic products. Applications of plant stem cell based cosmetics products comprises skin repair, anti-inflammatory, UV protection, under eye care, skin radiance, firming, anti-cellulite, and others (hydration, lip care, and antioxidant). According to market experts, the components found in these specific plants have been demonstrated to be a significant source of phyto stem cells.
This report on plant stem market for nutrients studies various applications of plant stem cell-based nutrients products. Applications of plant stem cell based nutrition products comprises develop natural mechanism, develop stem cell physiology, cellular rejuvenation, weight loss, anti-wrinkle & others (skin hydration, antioxidant, and others). Researchers suggest that plant stem cells contain two key components: growth factors, which play a role in cell division, the growth of new cells, and the production of collagen and elastin; and proteins, which regulate that stem-cell division.
This report on nanobiotechnology market studies various technologies and application. Nanobiotechnology deals with biological and biochemical applications or applications. Nanobiotechnology mostly studies existing elements of living organisms and nature to fabricate new nano-devices. The potential uses and benefits of nanotechnology are vast. The major applications of nanobiotechnology exist in biomedical field and are primarily targeted towards development of novel drug delivery systems, and it is expected to remain the major application of nanobiotechnology throughout the forecast period.
Industrial microbiology refers to screening of microorganisms for production of pharmaceuticals, food and beverage, personal care products and other applications. The industrial microbiology market is significantly large and is perpetually growing. Industries worldwide perform billions of tests every year thus representing substantial market potential.
Supplements are generally those products which are utilized to enhance, support to any kind of insufficiency in human body. It is usually taken in the form of pills, capsules, powder, and liquid or in softgels form or tea bag. These are generally extracted from herbal or botanical sources. Botanical supplements are generally utilized to treat a range of mental and physical ailments.
Conventionally, 2D cell culture have being used regularly in laboratories across the world. However, 2D cell culture has become primitive and are not able to replicate the exact in vivo environment. With advent of technology 3D cell culture model is able to exhibit similar environment close to the complex in vivo conditions. 3D cell culture is the assembly of living cell in three dimensional structure resembling particular tissue and organ microarchitecture. 3D cell culture can be made using scaffold or scaffold-free methods. 3D Cell culture model have wide range of applications ranging from tissue engineering to drug development, discovery and screening.
Global biologics market accounted for market value of US$ 254.9 Bn in 2017 and expected to attain US$ 580.5 Bn by 2026. Recombinant therapeutic proteins contributed largest market share in 2017 while cellular and gene therapies exhibited fastest annual growth during the forecast period from 2018 to 2026.
Plant-based meat protein is treated as an animal meat protein substitute which is mainly made of soy or gluten. It does not involve any animal product like meat or dairy. There are two methods by which plant-based meat products are processed: thermoplastic extrusion and fiber spinning.
Cell proliferation kits are assay based test solutions that aid in the quantification of cell proliferation and viability. Proliferation tests are based on the division of tetrazolium salt WST-1 to formazan by the activity of cellular mitochondrial dehydrogenases.
The oncology biosimilars market stood at US$ 1,651.5 Mn in 2017 and projected to exhibit a double-digit compound annual growth rate (CAGR) of 28.3% during the forecast period from 2018 to 2026. According to U.S. Food and Drug Administration, biosimilars are biological medicines that contain a highly similar version of the active substance of an already approved biologic, commonly referred to as the reference product.
The global tissue banking market is growing fruitfully, was valued at US$ 1,656.7 Mn in 2017 and expected to reach US$ 3,674.5 Mn by 2026. Worldwide growing cardiovascular procedures, utilization of advanced equipment types for excessive storage and preservation of human cells & tissues drives the overall market growth.
The global bacteriophage market held US$ 567.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. Bacteriophages are estimated as the most widely distributed and varied entities in the biosphere. From the initial research that defined the nature of viruses, bacteriophages have become model organisms for understanding the biochemistry.
The human microbiome market is set to reach US$ 1,990.5 Mn by 2026 from US$ 840.1 Mn in 2017 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2018 to 2026. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020.
Biotechnology Market Research Reports
Biotechnology is defined as the use of cell materials and living cells that conducts research and experiments to produce pharmaceutical and diagnostic items used in prevention and cure of human ailments. It is a one of the exceptionally rarest combination of cross-section disciplines that include biology, biochemistry, physics, genetic engineering, chemistry, biomedicine, microbiology, immunology, virology, biostatistics, botany, product reengineering, Pharmacology and material science.
Medical and scientific breakthroughs like environmental cleanup methods, microbial pesticides, disease resistant crops and insect resistant crops are introduced in the market due to medical biotechnology. A few most noticeable breakthroughs in this arena include discovery of insulin and growth hormone.
Pharmaceuticals biotechnology is a growing area of medical technology and medical sciences which contributes to supply of new beneficial drugs in the biotechnology market. Factors like growth of diagnostic agents for medical tests and gene therapy for altering the medical symptoms of inherited diseases are vital components of biotechnology.
Research experiments & trials carried out in biotechnology sector include stem cell research and human genome project. Stem cell therapy is the used to avoid or cure disease by using stem cells. Stem Cell therapy is used to regenerate the damages body exterior or interior parts and tissues. It is also used to cure dreaded diseases like cancer, Parkinson disease and Alzheimer disease. Human genome project helps in locating defective genes in the gene code sequence and disables their defective functionalities to get rid of the genetic diseases. Thus human genome project contributes towards annihilation of genetically transmitted diseases such as diabetes, hypertension and color blindness observed in our society.
The worldwide biotechnology sector is expected to earn revenue of more than $ 300 billion by the end of year 2015. Asian countries such as India and China are the most prominent as well as attractive markets of agronomic and industrialized biotechnology sector.
The biotechnology industry market reports segment of Acute Market Reports includes optimum information on the biopharmaceutical section primarily constituting of vaccines, branded remedial medications, generic pills, insulin and monoclonal antibodies. We have a vast collection of market research reports and analysis intended to make your search easy offering you with authentic information Our market research reports provides you ideal market research analysis of the biotechnology industry that will assist you in taking accurate business decisions contributing towards your business growth & expansion.
